This site is intended for Healthcare professionals only.

Sun Pharma acquires Japan Pola Pharma to strengthen dermatology segment


Sun Pharma acquires Japan Pola Pharma to strengthen dermatology segment
Sun Pharma had entered into a definitive agreement to acquire Pola Pharma, which is engaged in research and development, manufacture, sale and distribution of branded, and generic products in Japan, it said in a regulatory filing dated 26 November 2018.

Pola Pharma’s portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama with capabilities to manufacture topical products and injectables, it added.

Sun Pharma had forayed into the Japanese prescription market in 2016 with the acquisition of 14 established prescription brands from Novartis.

Read Also: Sun Pharma to acquire Japan’s Pola Pharma for Rs 7 crores approx



Source: With input
0 comment(s) on Sun Pharma acquires Japan Pola Pharma to strengthen dermatology segment

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted